**Core Concept**
Bone resorption is a complex physiological process involving the coordinated action of various cells and molecules. It is crucial for bone remodeling, a continuous process that maintains bone health and density. However, excessive bone resorption can lead to bone diseases such as osteoporosis.

**Why the Correct Answer is Right**
Interferon-gamma (IFN-γ) is a cytokine that primarily plays a role in immune responses, particularly in the activation of macrophages and the induction of Th1 cell responses. While IFN-γ has various effects on bone metabolism, it is not a significant player in the regulation of bone resorption. In contrast, the other options are well-established regulators of bone resorption.

**Why Each Wrong Option is Incorrect**
**Option A:** Parathyroid hormone (PTH) is a key regulator of bone resorption, acting through its receptors on osteoblasts and osteoclasts to stimulate the activation of osteoclasts and the subsequent resorption of bone matrix. PTH is a critical hormone in the regulation of calcium homeostasis and bone metabolism.
**Option B:** Interleukin-1 (IL-1) is a pro-inflammatory cytokine that plays a significant role in the regulation of bone resorption. IL-1 acts on osteoblasts to stimulate the production of RANKL, a protein that activates osteoclasts and promotes bone resorption.
**Option C:** Interleukin-6 (IL-6) is another cytokine involved in the regulation of bone resorption. IL-6 acts on osteoblasts to stimulate the production of RANKL and also directly stimulates the activity of osteoclasts, contributing to bone resorption.

**Clinical Pearl / High-Yield Fact**
A key clinical correlation is the use of bisphosphonates, a class of drugs that inhibit bone resorption by targeting osteoclasts. Bisphosphonates are commonly used in the treatment of osteoporosis and other bone diseases characterized by excessive bone resorption.

**Correct Answer Line**
✓ Correct Answer: D. Interferon-gamma.